Member Info for WBAFC

Novacyt will be mid cap and so this share price will rerate . Novacyt is simply the best diagnostic company out there with block buster innovative products that will be in demand worldwide . These MMs are milking it to the maximal knowing the strong interest from private investors in this company .

This share price is shot down by MMs / shorters as much as possible . It is simply divorced from what is actually happening with novocyt the company . So , the RNS last week was brilliant and you telling me thats only worth a £1 increase from what £3.80 which was the price prior to that RNS . The MMs have shot down the excited sentiment as well now. This is how these bankers make millions every year from us private investors . Its all corrupt .

Its so blatant that these shares are deliberately taken as low as possible. Shorters / MMs / ODDO are not allowing this shares to correlate with how successful Novocyt is . Novocyt is the best diagnostic company in UK , cash rich , and with block buster innovative products .

What we need is novocyt to maximise international revenues and announce its international updates to protect its long term genuine share holders from manipulated market makers . I am keen to see novocyt explore its business potential within India / USA / Europe. A positive RNS of its business updates internationally would certainly protect us long term share holders from these sharks that deliberately keep these shares down.

What we need is the BOD to announce international strategy of generating revenue and of course announce a huge billion dollar deal with USA / India . Then this share price will rocket from £20 tomorrow at 8am .

I would like novocyt to increase their international sales as thats where the huge revenues are now.... I would like to see RNS highlighting what we are doing internationally .

Novocyt is the one to buy , best diagnostic covid-19 variant pcr in the world. Any new potential investors, put your money into novocyt shares. Its a winner.
Covid-19 is going to be here for a long long time , variants are emerging all the time. A more dangerous variant found in Sri Lanka now. Novocyt will develop their SNPsig to detect this as well.

https://youtu.be/pFGjB-cT30c

Are novocyt BOD legally required to announce big contracts won abroad ? We did win £12M unicef contract for Ukraine , which was not declared. I would like more information on RNS on world contracts won . India / USA / Latin America would certainly be massive and send this company to mid capitalization in no time . Does any know also what the novocyt share split with UK & France is now ?

I would love novocyt to announce a huge contract from india next week for its new SNPsig detecting the indian double mutation. India is desperate for help as their PCR tests are missing these double mutated covid-19 viruses.

The following statement is taken from primer design website.

''SNPsig® is the world’s most comprehensive portfolio of SARS-CoV-2 variant identification assays.''

That test will be a blockbuster worldwide for novocyt , together with all the product portfolio available .

The CEO has 122,506 shares in novocyt @ total cost of £526,428.
60,875 shares @ £8.17
9,493 shares @ £3.10
52,138 shares @£0

His shares are worth now @ £3.705 is £453,884

So he is @ loss of £72,543 as it stands.

I dont believe he will be happy with this , even though he is a multimillionaire . He is share holder just like we are and has stated that he wants to grow the company into a mid cap organisation.

Have the faith.

Yesterday over 2000 lives lost in India and in Brazil over 3000 lives lost both from covid-19. We will get another wave of covid-19 this summer in UK.

Huge business to be made by novocyt. Need to tap into India and Latin America more.

https://www.worldometers.info/coronavirus/?utm_campaign=homeAdUOA?Si#countries

Adam _

We have 2 distributors in India and 4 in USA .
We need 10 distributors in India , India is made up of huge number of states .

E_AL

I guess Having Guilermo Raimondo will cover our Latin America , What About India ? The covid-19 wave is massive there

I was reviewing the RNS 29th January 2021 in detail.

It states : ''Organically, Novacyt will continue to invest in its commercial infrastructure to deliver new products, as the Company continues to redefine its R&D pipeline and establish a direct sales force in key markets in the US and across Europe. ''

I wonder what are the thoughts of share holders regarding this statement above , as I personally believe Novocyt should also be looking at India's and Latin American Covid-19 explosion , and thinking this is something they can exploit and create huge business in those areas of the world . I really hope the BOD are looking into this . They should not just rely on UK business only .

@ this share prices of Novocyt currently it really is a massive opportunity to invest in this brilliant innovative company that will grow and expand further creating true share investor value with time .

I hope novocyt are pitching their sales consultants in key areas of the world , India , Brazil , other Latin countries,
USA , Europe , Africa , Canada . So many contracts to win and deliver great novocyt products to save the world !

200k novocyt stock dumped this morning on French market. This is what created panic and brought share price down . Is this blackrock dumping ----> buying ---> rinsing ? or market makers playing games as they buy up least 10% of shares and dump when they want to bring price down ?

Don't worry guys these are all games played by MMs . They want your shares and that's why they are dropping the share price to scare your pants off . I think Black Rock and other Institutional Investors are buying and rinsing the shares - easy money to make this way . I am sure the BOD @ novocyt are completely aware of what is going on and given MMs freedom to do whatever they like

The CEO of Novocyt talked about bolt on acquisitions at previous RNS to 'grow and expand ' novocyt. My gut feeling is that we will be owning Cambridge Clinical Labs who are involved in this £15bn Lot4 as stated previously....

Just imagine part of this £15B coming to Novocyt .. wow !

I forget to mention also the saliva PCR testing that Novocyt have .

taken from Novocyt R&D update 24th February 2021 :

Successful implementation of saliva testing of AstraZeneca staff using the genesig® COVID-19 assay

In early 2020, AstraZeneca set up an internal programme of voluntary SARS-CoV-2 testing for asymptomatic employees in the UK and Sweden using Novacyt’s genesig ® COVID-19 test. By February 2021, approximately 70,000 SARS-CoV-2 PCR tests had been completed within AstraZeneca’s internal global testing centres, of which 54,000 are based on saliva swabs. Following the introduction of saliva testing, adoption by employees increased approximately four-fold and over 90% of 1,062 employees surveyed expressed a preference for the change from the typical oropharyngeal (throat) or nasopharyngeal (nasal) swabs. The study highlights the 90% uptake of saliva testing for asymptomatic patients and the excellent detection rates of 0.33 copies of whole viral genome RNA/µL, sensitivity of =95% and 100% specificity.9 These result shows how PCR testing can be used for asymptomatic mass-testing.

I have put this out again for the sake of any new potential investors and any existing investors .

Remember we have very good products on the market which will sell to the private and international sectors . We are selling to 150 countries . Furthermore Q1 sales to private sectors was 50% of total revenue , this will only increase now to replace that UK GOV contract . We can sell internationally to our terms and not be restricted to any price controls from UK GOV .

Remember we have products that can pick up different variants of covid-19 , this will be in huge demand world wide as well as in UK . We have mobile PCR devices that can be used at airports , sports stadiums , and other places that need accurate results . We also have LFT that can be use by vaccinating companies to check uptake of immunity . There is so much going on with this company that its the best company in UK to invest in for diagnostics . I am a UK full time General Practitioner and I can tell you this company is the best in its field in the UK .
I Did so much research in this company before investing .

Novocyt are launching a antigen LFT this Q2 which will be a game changer to the accuracy of LFTs out there .

I have stolen this from sly_london who summarizes perfectly everything from Friday's RNS 9th April 2021 .

There are many clues in the wording that should give investors confidence:

"parties in dispute" - means that the contract not 100% cancelled
"strong grounds to assert its contractual rights" - NCYT may well get the contract extension.
"continued growth of international sale"
"expansion of private sector testing"
"new contract wins will continue"
"encouraged by demand for....SNPsig"
"New COVID-19 lateral flow products"
"continues to expand its product portfolio and service offering"
"well positioned to capitalise on future growth opportunities"

Clearly this is a solid company, debt free and holding a large cash position. An extremely low risk investment at this SP.
GLA